DE69810724D1 - Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC) - Google Patents
Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC)Info
- Publication number
- DE69810724D1 DE69810724D1 DE69810724T DE69810724T DE69810724D1 DE 69810724 D1 DE69810724 D1 DE 69810724D1 DE 69810724 T DE69810724 T DE 69810724T DE 69810724 T DE69810724 T DE 69810724T DE 69810724 D1 DE69810724 D1 DE 69810724D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibitor
- protein
- dic
- treatment
- intravascular coagulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000000873 Protein C Inhibitor Human genes 0.000 title abstract 2
- 108010001953 Protein C Inhibitor Proteins 0.000 title abstract 2
- 229940122929 Protein C inhibitor Drugs 0.000 title abstract 2
- 208000009190 disseminated intravascular coagulation Diseases 0.000 title 1
- 206010020608 Hypercoagulation Diseases 0.000 abstract 1
- 230000023555 blood coagulation Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003027 hypercoagulation Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9230294A JPH1160500A (ja) | 1997-08-11 | 1997-08-11 | 血液凝固異常亢進抑制剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69810724D1 true DE69810724D1 (de) | 2003-02-20 |
DE69810724T2 DE69810724T2 (de) | 2003-05-08 |
Family
ID=16905575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69810724T Expired - Fee Related DE69810724T2 (de) | 1997-08-11 | 1998-08-11 | Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC) |
Country Status (6)
Country | Link |
---|---|
US (1) | US5948752A (de) |
EP (1) | EP0904785B1 (de) |
JP (1) | JPH1160500A (de) |
AT (1) | ATE231001T1 (de) |
CA (1) | CA2244801A1 (de) |
DE (1) | DE69810724T2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002010783A (ja) * | 2000-06-29 | 2002-01-15 | Jcr Pharmaceuticals Co Ltd | 改変型ヒトプロテインcインヒビター |
TW200407335A (en) * | 2002-07-22 | 2004-05-16 | Chugai Pharmaceutical Co Ltd | Non-neutralizing antibody to inhibit the inactivation of activated protein C |
WO2004065418A1 (ja) * | 2003-01-20 | 2004-08-05 | Chugai Seiyaku Kabushiki Kaisha | 抗pci中和抗体 |
FR2945126B1 (fr) * | 2009-04-29 | 2019-11-01 | Commissariat A L'energie Atomique | Procede et appareil de comptage des thrombocytes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3705745A1 (de) * | 1987-02-23 | 1988-09-01 | Behringwerke Ag | Protein c-inhibitor (pci) als pharmazeutikum und in vitro-diagnostikum, verfahren zur herstellung eines solchen pharmazeutikums oder diagnostikums sowie ein mittel enthaltend pci |
AU2299592A (en) * | 1991-07-02 | 1993-02-11 | Children's Medical Center Corporation | Treatment of periodontal disease with protease inhibitors |
-
1997
- 1997-08-11 JP JP9230294A patent/JPH1160500A/ja active Pending
-
1998
- 1998-08-11 CA CA002244801A patent/CA2244801A1/en not_active Abandoned
- 1998-08-11 DE DE69810724T patent/DE69810724T2/de not_active Expired - Fee Related
- 1998-08-11 EP EP98115110A patent/EP0904785B1/de not_active Expired - Lifetime
- 1998-08-11 AT AT98115110T patent/ATE231001T1/de not_active IP Right Cessation
- 1998-08-11 US US09/132,534 patent/US5948752A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69810724T2 (de) | 2003-05-08 |
ATE231001T1 (de) | 2003-02-15 |
JPH1160500A (ja) | 1999-03-02 |
US5948752A (en) | 1999-09-07 |
EP0904785A1 (de) | 1999-03-31 |
EP0904785B1 (de) | 2003-01-15 |
CA2244801A1 (en) | 1999-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE114113T1 (de) | Verwendung von droloxifen bei der behandlung von knochenerkrankungen. | |
DK0797666T3 (da) | Genetisk manipulerede humane Kunitz-domæner, der inhiberer human neutrofil elastase | |
BR9507758A (pt) | Fração de copolímero-1 e composição para o tratamento de esclerose múltipla | |
PT842934E (pt) | Agonistas de 5-ht1f | |
NO912630D0 (no) | Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler. | |
DE69130614D1 (de) | Herbizide, substituierte aryl-haloalkylpyrazole | |
MXPA02001911A (es) | Anticuerpos ctla-4 humanos y sus usos. | |
DE69521620D1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
ATE271390T1 (de) | Verwendung von azithromycin zur topischen behandlung von augeninfektionen | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
FI924424A (fi) | Hjaertskyddande tokoferolanaloger | |
DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
DE69810724D1 (de) | Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC) | |
FI904852A0 (fi) | Antikoagulantpeptider. | |
BR9612074A (pt) | Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas | |
ES2073391T3 (es) | Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre. | |
SE9003374D0 (sv) | A collagen binding protein as well as its preparation | |
ITMI920955A1 (it) | Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili | |
DK0435177T3 (da) | 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler | |
ATE273711T1 (de) | Verwendung von niedermolekularem heparin zur behandlung und/oder prophylaxe motoneuronaler krankheiten | |
DE69905489D1 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
ATE282609T1 (de) | Neue substituierte n-methyl-n-(4-(4-(1h- benzimidazol-2-yl) (1,4)diazepan-1-yl)-2- (aryl)butyl)benzamide zur behandlung von allergischen krankheiten | |
ATE359088T1 (de) | Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten | |
ATE292970T1 (de) | Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |